{
 "PrintNo":"A509","Session":2019,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2019-01-07T12:26:46.464356Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2020-01-08","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2019-01-09","Chamber":"ASSEMBLY"},
  {"Text":"REFERRED TO HEALTH","Date":"2020-01-08","Chamber":"ASSEMBLY"}
 ],
 "Sponsors":[{"ID":610,"Name":"Edward Braunstein","Short":"BRAUNSTEIN"},{"ID":1259,"Name":"Jonathan Jacobson","Short":"JACOBSON"}],
 "Title":"Relates to adding W-18 to the schedule of controlled substances",
 "Summary":"Adds W-18(4-chloro-N-[1-[2-(4-nitrophenyl)ethyl] 2piperidinylidene]benzenesulfonamide) to the schedule of controlled substances.",
 "LawSection":"Public Health Law","LawCode":"Amd ยง3306, Pub Health L",
 "ActClause":"AN ACT to amend the public health law, in relation to adding W-18 to the schedule of controlled substances",
 "SameAsPrintNo":"S5221-2019","PreviousVersions":["A3030-2017"]
}